This site is intended for healthcare professionals only
LoginRegister
Aurobindo Pharma arm Unit IV gets 5 USFDA observationsDivi's Labs gets one USFDA observation for Visakhapatnam facility
Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance FailuresCaplin Steriles gets USFDA nod for Ephedrine Sulfate injection
ZydusUSFDA nod to Zydus Lifesciences diabetes drug
USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three ObservationsZydus Lifesciences gets USFDA OAI status for Jarod facility
Dr Reddys Russia Arm Slapped Rs 2.45 Cr VAT PenaltyDr Reddy's Laboratories Gets CDSCO Panel Nod To Manufacture, Market Elobixibat Tablet
Imbruvica gets positive EMA Committee opinion for untreated mantle cell lymphoma eligible for Stem Cell Transplant: Janssen-Cilag InternationalJohnson & Johnson beat estimates for Q2 profit, revenue
Bad Times for Sanofi Healthcare? Market Signals Suggest Growing PressureSanofi Healthcare to infuse Euro 400 million in Hyderabad GCC by 2030
Union Health Minister emphasizes on continuous dialogue with pharma, medical devices industry to ensure highest quality of productsUnion Health Minister emphasizes on continuous dialogue with pharma, medical devices industry to...
foreign-qualified woman doctor shot deadAP: Lava fell on worker accidentally at Pharma co, died
Govt extends deadline for submitting applications under PLI SchemeIndian pharma, healthcare sector record 55 deals totaling USD 4.1 billion in Q2 2024
Intas PharmaIntas Pharmaceutical Gets CDSCO Panel Nod to Study Atorvastatin plus Fenofibrate FDC
USFDA Concludes PAI at Cipla Subsidiary InvaGen With 2 ObservationsIT Department sends Rs 773 crore demand notice to Cipla
X